(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ULORIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ULORIC

ST13

US500000078108573

Class

5

Filing

78108573

Registration

2739132

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

09/29/2023

Trademark type

Word

Nice classes

5

Filing date

02/13/2002

Registration date

07/15/2003

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/29/2023

Last transaction

09/29/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/14/2002

First use in commerce

02/14/2002

Drawing code

1

Owner type

03

Owner location

Kita-ku, Osaka, JP

Examiner

THOMAS, AMY E

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED)
TAKEDA PHARMACEUTICALS U.S.A., INC.
TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
TAP Pharmaceutical Products Inc.

Representatives

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

PHARMACEUTICAL PREPARATIONSNAMELY XANTHINE OXIDASE INHIBITORS

Publications

History of USPTO decisions and trademark events.

36 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/29/2023

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

09/29/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/29/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/29/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

03/27/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/15/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/22/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/21/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/21/2015

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/16/2013

NA15

SEC. 15 ACKNOWLEDGEMENT - E-MAILED

07/16/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/16/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/16/2013

15AK

REGISTERED - SEC. 15 ACKNOWLEDGED

07/16/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

07/08/2013

E15R

TEAS SECTION 15 RECEIVED

07/08/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/08/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/08/2012

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/08/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/29/2011

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

08/10/2009

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/29/2009

PLGL

ASSIGNED TO PARALEGAL

07/21/2009

ES8R

TEAS SECTION 8 RECEIVED

07/15/2009

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/17/2008

CFIT

CASE FILE IN TICRS

05/23/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

07/15/2003

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/12/2003

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/28/2003

IUAF

USE AMENDMENT FILED

03/31/2003

EISU

TEAS STATEMENT OF USE RECEIVED

03/31/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

01/21/2003

PUBO

PUBLISHED FOR OPPOSITION

10/29/2002

NPUB

NOTICE OF PUBLICATION

10/09/2002

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/03/2002

DOCK

ASSIGNED TO EXAMINER

06/24/2002

Continuous trademark protection

Get notified about every new filing that threatens ULORIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.